All > Radiotherapy > Glioma

Hydrogen for Malignant Glioma

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Malignant GliomaHydrogen - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will explore whether hydrogen rich water can improve quality of life for brain cancer patients undergoing radiation and chemotherapy.

Eligible Conditions
  • Malignant Glioma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Evolocumab
1
Resection/Treatment with Niraparib
1
Hydrogen tablets

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 3 years

2 years
European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLQ) BN20 score
European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life (QLQ) C30 score
Karnofsky performance score (KPS)
Memory
Overall survival and progression free survival (PFS)
3 years
Patient enrollment statistics

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Evolocumab
1
Resection/Treatment with Niraparib
1
Hydrogen tablets

Trial Design

2 Treatment Groups

Hydrogen
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

15 Total Participants · 2 Treatment Groups

Primary Treatment: Hydrogen · Has Placebo Group · Phase 2

Hydrogen
Drug
Experimental Group · 1 Intervention: Hydrogen · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo oral tablet · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hydrogen
Not yet FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 years

Who is running the clinical trial?

Stony Brook UniversityLead Sponsor
199 Previous Clinical Trials
35,028 Total Patients Enrolled
Agnieszka Kowalska, MDPrincipal Investigator - Stony Brook Medicine
Stony Brook University Medical Center
Ross University (Medical School)
University Hosp-Suny Stony Brook (Residency)
1 Previous Clinical Trials
106 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a KPS of at least 70.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top